BRUSSELS, Oct 2 (Reuters) - Shares in Ablynx hit a new one-year high after the Belgian drug developer announces it is entering into a potentially lucrative partnership with Merck & Co .
The shares rise as much as 4.1 percent in early trading to 4.80 euros.
(Reporting by Philip Blenkinsop)
Keywords: ABLYNX MERCK/SHARES